"Preemptive" live donor liver transplantation for fibrolamellar hepatocellular carcinoma: a case report.

Abstract

Fibrolamellar (FL) hepatocellular carcinoma (HCC) is a distinctive form of primary HCC that occurs principally in children and young adults. Although liver transplantation is not contraindicated for FL-HCC, noncirrhotic patients with large HCC tumors (including FL-HCCs) are not prioritized. Although hepatic resection is considered to be the primary treatment for FL-HCC, living donor liver transplantation is evolving into a potentially better alternative. Herein we have reported successful "preemptive" living donor liver transplantation for presumed recurrence of FL-HCC after an extended right hepatectomy with resection and synthetic graft replacement of the inferior vena cava.

• Authors: I Fouzas, G C Sotiropoulos, E P Molmenti, S Beckebaum, K J Schmitz, C E Broelsch, H Lang, M Malagó
• Journal: Transplantation proceedings (Transplant Proc) Vol. 40 Issue 10 Pg. 3806-7 (Dec 2008) ISSN: 0041-1345 [Print] United States
• PMID: 19100497 (Publication Type: Case Reports, Journal Article)

Chemical References

• factor V Leiden
• Factor V

Topics

• Adult
• Carcinoma, Hepatocellular (diagnostic imaging, pathology, surgery)
• Combined Modality Therapy
• Factor V (genetics)
• Female
• Humans
• Liver Neoplasms (diagnostic imaging, pathology, surgery)
• Living Donors
• Mutation
• Radiography
• Safety